hTERT and IGF-1R Proteins Expression in Response to Treatment in Patients with HPV Alpha 9-Positive Cervical Cancer

©2023 by Radiation Research Society. All rights of reproduction in any form reserved..

Human papillomavirus (HPV) infection is strongly associated with cervical cancer (CC). Genomic alterations caused by viral infection and subsequent dysregulation of cellular metabolism under hypoxic conditions could influence the response to treatment. We studied a possible influence of IGF-1Rb, hTERT, HIF1a, GLUT1 protein expression, HPV species presence and relevant clinical parameters on the response to treatment. In 21 patients, HPV infection and protein expression were detected using GP5+/GP6+PCR-RLB and immunohistochemistry, respectively. The worse response was associated with radiotherapy alone compared with chemoradiotherapy (CTX-RT), anemia and HIF1a expression. HPV16 type was the most frequent (57.1%) followed by HPV-58 (14.2%) and HPV-56 (9.5%). The HPV alpha 9 species was the most frequent (76.1%) followed by alpha 6 and alpha 7. IGF-1Rb (85.7%), HIF1a (61.9%), GLUT1 (52.3%), and hTERT expression [cytoplasm and nucleus (90.4%)] were detected. The MCA factorial map showed different relationships, standing out, expression of hTERT and alpha 9 species HPV, expression of hTERT and IGF-1Rb expression [Fisher's exact test (P = 0.04)]. A slight trend of association was observed between, GLUT1 and HIF1 a expression, hTERT and GLUT1 expression. A noteworthy finding was the subcellular localization of hTERT in the nucleus and cytoplasm of CC cells and its possible interaction with IGF-1R in presence of HPV alpha 9 species. Our findings suggest that the expression of HIF1a, hTERT, IGF-1Rb and GLUT1 proteins that interact with some HPV species may contribute to cervical cancer development, and the modu lation of treatment response.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:199

Enthalten in:

Radiation research - 199(2023), 5 vom: 01. Mai, Seite 452-459

Sprache:

Englisch

Beteiligte Personen:

Moreno-Acosta, Pablo [VerfasserIn]
Gamboa, Oscar [VerfasserIn]
González-Prieto, Cristian [VerfasserIn]
Romero-Rojas, Alfredo [VerfasserIn]
Serra, Josep Balart [VerfasserIn]
Díaz, German Dario [VerfasserIn]
Malaver, Gina [VerfasserIn]
Bouleftour, Wafa [VerfasserIn]
Magné, Nicolas [VerfasserIn]

Links:

Volltext

Themen:

EC 2.7.7.49
Glucose Transporter Type 1
Journal Article
Research Support, Non-U.S. Gov't
Telomerase

Anmerkungen:

Date Completed 29.05.2023

Date Revised 16.06.2023

published: Print

Citation Status MEDLINE

doi:

10.1667/RADE-22-00121.1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353944602